May 2026

Updates You Don't Want Your Team to Miss

New Oral GLP-1 Agonist, Orforglipron

Teams will need to be ready with guidance about orforglipron, the second oral GLP-1 receptor agonist approved for adults who are overweight or obese. Our articles discuss orforglipron’s dosing, administration, efficacy, and side effects, and how it compares to the other oral GLP-1 agonist, semaglutide. We also give guidance about patient counseling and error prevention. Readers can see how orforglipron stacks up with our GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart and Comparison of Weight Loss Products resource.  

Read More:

Community Pharmacies: New Cholesterol Guidelines – Screening, Risk, and Targets

Big changes in guidelines will bring up questions about managing cholesterol for primary CV prevention. Our articles give guidance about when to screen patients with a lipid panel and how to estimate CV risk in patients without CV disease. We also discuss treatment considerations and LDL targets. Readers can get more guidance in our updated Cholesterol Guidelines resource.  

Read More:


Hospitals: Updated Sepsis Guidelines

Hospitals will need to revise their adult sepsis protocols due to updated guidelines. Our articles review key practice changes such as tighter antibiotic-timing targets. We also outline blood pressure goals, when to consider GI decontamination, and considerations about antibiotic de-escalation. Readers can dive deeper into sepsis treatment in our updated resource, Sepsis Management in Adults.

Read More:

Natural Medicines

Sea Moss 101: Separating the Hype from the Hard Evidence  

Patients are asking about sea moss after seeing celebrities and influencers promote it for everything from skin health to gut health and immune support. Our NatMed article breaks down what sea moss is and what the evidence actually shows. The bottom line: there are no well-designed clinical trials supporting sea moss for any specific condition. It’s likely safe in food amounts for most people, but patients with thyroid conditions or those taking thyroid medications like levothyroxine should be cautious due to its variable iodine content. Supplements are a bigger concern since many don't specify iodine content.  

Sea Moss 101: Separating the Hype from the Hard Evidence  

Patients are asking about sea moss after seeing celebrities and influencers promote it for everything from skin health to gut health and immune support. Our NatMed article breaks down what sea moss is and what the evidence actually shows. The bottom line: there are no well-designed clinical trials supporting sea moss for any specific condition. It’s likely safe in food amounts for most people, but patients with thyroid conditions or those taking thyroid medications like levothyroxine should be cautious due to its variable iodine content. Supplements are a bigger concern since many don't specify iodine content.  

New Podcast!
Natural Medicines: Evidence in Practice

Our new podcast, Natural Medicines: Evidence in Practice, is now streaming! In our latest episode, Migraines: Counseling Patients on Natural Treatment Options, NatMed editors Jeff Langford, PharmD, BCPS, BCCP; Andrea Stafford, PharmD; and Kelly Daniels break down the evidence behind common natural medicines for migraines and discuss how clinicians can help patients match the right option to the right goal… prevention versus acute treatment, while setting realistic expectations at the point of care.

Podcast Episodes

Pharmacy and Prescriber Podcasts

Medication Talk

Listen to this month’s podcast episode, GLP-1 Agonists: Clinical Conundrums, as our expert panel tackles real-world questions about GLP-1 agonists, from starting them and setting expectations with patients to strategies for switching agents. You’ll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don’t respond to GLP-1 agonists. 

All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.  

medication talk on phone with headphones

Rumor vs Truth

Listen to the latest episode, Artificial Intelligence, as our editors explore dive into current claims around artificial intelligence in pharmacy practice to sort out which ones are medical truths versus risky rumors. 

All Rumor vs Truth podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.

 

Clinical Capsules

Listen to our latest episode, Managing Opioid Overdose: Signs, Symptoms, and Reversal Agents, as Associate Editor and Clinical Pharmacist Don Weinberger discusses how to recognize opioid overdose, compares naloxone and nalmefene options including the new nalmefene auto-injector, and shares tips for patients and caregivers on using opioid reversal agents effectively.

All Clinical Capsules podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.

Upcoming Live CE Webinars for Your Clinicians

Hypertension Treatment Updates

Date: May 14  

In this month’s live webinar, Hypertension Treatment Updates, you’ll hear experts discuss the latest blood pressure thresholds, treatment targets, and the role of the PREVENT risk calculator. Experts will also explore the latest management strategies across diverse patient populations, such as those with diabetes or kidney disease. You’ll leave with practical, evidence-based strategies to optimize blood pressure control for your patients.

Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME: 

  • ACCME: 1.00 hour 
  • ACPE: 1.00 hour – pharmacists and technicians 
  • ANCC: 1.00 hour 

Register Now

Pharmacy Essential Updates 

Upcoming 2026 Live Webinars
Check out our upcoming Pharmacy Essential live CE webinars

Dates: May 16, 19, 21, 27

Topics for May include:

  • New oral GLP-1 agonist, orforglipron
  • Antiseizure meds review
  • Infant formulas
*Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar. 

View Live CE Webinars

Popular Clinical Resources

Magnesium Supplements

Comparison of Insomnia Treatments

Artificial Intelligence in Pharmacy Practice

Treatment of Mild to Moderate Ulcerative Colitis

New Specialty Pharmacy Courses Now Live

We’re excited to announce that we recently released a new suite of specialty pharmacy courses designed to help organizations strengthen staff expertise, support better clinical decision-making, and stay ahead of changes across high-impact therapeutic areas.

This latest release includes training across topics such as:

  • Specialty Therapies Across Inflammatory Bowel Disease and Other Gastrointestinal Conditions
  • Specialty Therapies Across Psoriasis and Psoriatic Arthritis
  • Specialty Therapies in Migraine Management
  • Specialty Therapies Across HIV: Treatment, PEP, and PrEP
  • Specialty Therapies Across Chronic Viral Hepatitis: Hepatitis B and Hepatitis C
  • Specialty Therapies for Atopic Dermatitis

Explore the full library.

The Specialty Pharmacy Training Library combines accredited clinical education with workflow-based operational training to help pharmacy teams consistently execute complex therapies—reducing risk, improving outcomes, and accelerating workforce readiness at scale. It’s now available within the Pharmacist Learning & Practice Suite and the Pharmacy Technician Learning & Practice Suite.

Group users can select the specialty pharmacy library filter from their CE & Training Organizer to see their available courses.

Contact us to confirm if your group has access to the Specialty Pharmacy Training Library. We’d be happy to discuss further.

Contact Us

Webinar Spotlight

Are You Able to Prove Compounding Competency at Audit? 

Compounding compliance is under increased scrutiny, and for many pharmacy leaders, the challenge is not just having the right policies in place but being able to prove training and competency. USP <795>, <797>, and <800> standards have tightened significantly since the latest 2023 revision, while teams continue to deal with documentation gaps. When inspectors arrive, assumed competency is not defensible. Documented competency is.

Join us for our webinar, From Compliance Risk to Audit Confidence: A New Approach for Compounding Pharmacies, on May 20 at 2:00 PM EST, where we’ll cover a more structured approach to compounding compliance and demonstrate how the Compounding Compliance Suite helps teams standardize practice and prove readiness.

Key Takeaways:

  • Why assumed competency creates audit risk and how to properly fulfill compliance requirements
  • How to ensure consistent compounding technique across sites and staff
  • A practical approach to meeting USP <795>, <797>, and <800> requirements
  • How to move from fragmented documentation to inspection-ready audit trails
  • A clearer way to track, validate, and prove staff competency in real time

Can’t attend live? Register anyway and we’ll send you the recording.

Please note: This webinar does not offer CE/CME credit.

Register Now

ASHP/ACPE 2026 Accreditation Standards Update 

The ASHP/ACPE 2026 Accreditation Standards for pharmacy technician education and training programs take effect January 1, 2027, and now is the time to prepare.

The updated framework consolidates 15 standards into five streamlined directives and includes key changes such as a single training level, a 400-hour minimum requirement, new guidance allowing Credit for Prior Experience under defined criteria, and more.

We are here to help you understand the changes, assess the impact, and transition with confidence.

About TRC Healthcare

TRC Healthcare provides unbiased education, training, and support to every healthcare professional to reduce knowledge gaps, encourage evidence-based practice, lower costs, and deliver better patient outcomes.
TRC Healthcare

© 2026 TRC Healthcare. All Rights Reserved.